e-Edition
Obituaries
Special Sections
Special Occasions
Contact
Subscribe
Paywall Login
Login to Comment
Register
December 11th, 2017
jobs
homes
Menu
Home
News
Sports
Business
Entertainment
Classifieds
Commentary
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about RHHBY
Recent news which mentions RHHBY
< Previous
1
2
...
7
8
9
10
11
12
13
14
15
...
18
19
Next >
A Major October Catalyst Could Make This Eye Stock A Ten Bagger, Analyst Says
September 13, 2022
Tickers
NVS
OTLK
REGN
RHHBY
Tags
Initiation
REGN
Health Care
From
Benzinga
A Quick Look At The OTC Markets' Most-Active Securities In August - Here's What You Need to Know
September 12, 2022
Tickers
ABML
ADDYY
BASFY
BFFAF
Tags
OTC Markets Group
IFNNY
RHHBY
From
Benzinga
Why Regeneron Pharmaceuticals Stock Is Crushing It Today
September 08, 2022
Tickers
BAYN
REGN
RHHBY
Tags
BAYN
RHHBY
REGN
From
Motley Fool
No More Free COVID-19 At-Home Tests, Federal Government Says
August 29, 2022
Tickers
A
ABT
BDX
BRKR
Tags
PKI
Health Care
News
From
Benzinga
Citi Is Bullish On This Large Pharma Stock On Upcoming Data Readout From Diabetes Candidate
August 25, 2022
Tickers
ESALF
ESALY
LLY
RHHBF
Tags
Market News
Benzinga
Price Target
From
Benzinga
China-Based Jemincare Inks Prostate Cancer Drug Pact With Roche's Genentech
August 18, 2022
Tickers
RHHBF
RHHBY
RHHVF
Tags
RHHVF
Biotech
Market News
From
Benzinga
Roche's Polivy Combo Regime Under FDA Review For Type Of Blood Cancer
August 16, 2022
Tickers
RHHBF
RHHBY
RHHVF
SGEN
Tags
General
Market News
Benzinga
From
Benzinga
OTC Markets' Most Active Securities Sees A Shake-up In July
August 16, 2022
Tickers
ADDYY
AYRWF
BASFY
BMIX
Tags
ZURVY
STEK
Market News
From
Benzinga
FDA Approves Expanded Use Of Roche's Influenza Treatment
August 12, 2022
Tickers
RHHBF
RHHBY
RHHVF
Tags
Biotech
RHHVF
Large Cap
From
Benzinga
Biotech Daily: Cancer Causing Impurities In Merck's Diabetic Drug, Vir Bio-GSK Shun FDA Submission Plans For COVID-19 Treatment, Aethlon's Monkeypox Trial
August 10, 2022
Tickers
ADMP
AEMD
ALPN
ARDS
Tags
AEMD
CNTA
BCDA
From
Benzinga
Amgen's Lumakras/Keytruda/Tecentriq Combo Data Flags Safety Concern
August 08, 2022
Tickers
AMGN
MRK
RHHBF
RHHBY
Tags
AMGN
General
Benzinga
From
Benzinga
These 2 Under-The-Radar Stocks Traded More Than $1B Each Last Month
August 05, 2022
Tickers
ADDYY
BASFY
BNPQY
BTC
Tags
DANOY
GBTC
BASFY
From
Benzinga
Biotech Daily: Merck's Two Combo Cancer Trials Miss Main Goal, Approval For Sinovac's COVID-19 Shot For Youngest Kids, Alnylam Aces Protein Disorder Trial
August 03, 2022
Tickers
ALNY
AMRN
ARQT
BMRN
Tags
PSTX
Market News
Benzinga
From
Benzinga
Kiniksa Inks Global License Agreement With Roche For Vixarelimab
August 03, 2022
Tickers
KNSA
RHHBY
Tags
Benzinga
Market News
Guidance
From
Benzinga
Poseida Shares Rally As Roche Takes Next Big Step Into Allogeneic CAR-T Field
August 03, 2022
Tickers
PSTX
RHHBF
RHHBY
RHHVF
Tags
RHHBF
Trading Ideas
RHHBY
From
Benzinga
Biotech Daily: Trial Setback For Eliem Therapeutics, Allarity Drops Work On Cancer Monotherapies, Axcella Aces Long COVID Study
August 02, 2022
Tickers
ABBV
ACIU
ALLR
AXLA
Tags
RHHBY
Trading Ideas
Earnings
From
Benzinga
How This Multibillion-Dollar Company Is Shaking Off the Competition
July 30, 2022
Tickers
CHGCY
REGN
RHHBY
Tags
RHHBY
Recent Press Releases
CHGCY
From
Motley Fool
Daily Biotech Pulse: Bausch Health To Appeal Xifaxan Patent Decision, Bristol Myers Drug Combo Fails In Kidney Cancer Trial, Sarepta's Duchenne Candidate Update
July 29, 2022
Tickers
ABBV
ADMP
ARQT
AZN
Tags
Penny Stocks
ICVX
Legal
From
Benzinga
Why Shares of Agenus Inc. Rose 10.1% on Tuesday
July 26, 2022
Tickers
AGEN
RHHBY
Tags
AGEN
RHHBY
Recent Press Releases
From
Motley Fool
Regeneron's Price Target Cut On Dim Prospects For Its Flagship Eye Product
July 25, 2022
Tickers
REGN
RHHBF
RHHBY
RHHVF
Tags
News
Health Care
REGN
From
Benzinga
Daily Biotech Pulse: Liver Disease-Focused Gene Therapy Pact, Assembly Bio Stops HBV Infection Trial, X4 Pharma Looks For Partners
July 21, 2022
Tickers
ABBV
ABUS
ASMB
HLVX
Tags
ASMB
OLMA
RHHVF
From
Benzinga
Benzinga Before The Bell: Baidu Beats Tesla, Finland Sells $47.5M Bitcoins, Tesla's Bitcoin Sale And Other Top Financial Stories Thursday, July 21
July 21, 2022
Tickers
AAPL
AMZN
BIDU
BIIB
Tags
$ETH
GOOG
DIDIY
From
Benzinga
Roche's Long-Time CEO Passes Baton, Higher Diagnostics, Medicine Sales Lift 1H Sales & Profit
July 21, 2022
Tickers
RHHBF
RHHBY
RHHVF
Tags
Earnings
RHHBF
RHHBY
From
Benzinga
Novartis Posts Mixed Q2 Earnings, Expects Improved Earnings At Sandoz
July 19, 2022
Tickers
NVS
RHHBY
Tags
Briefs
Health Care
News
From
Benzinga
Mortgage Financiers & Crypto Securities Reclaim Their Spots As Most Actively Traded Securities On OTC Markets In June
July 18, 2022
Tickers
ADDYY
AERG
AXAHY
BNPQY
Tags
DANOY
RHHBY
IFNNY
From
Benzinga
Roche Launches Dual Antigen & Antibody Hepatitis C Diagnostic Test
July 18, 2022
Tickers
RHHBF
RHHBY
RHHVF
Tags
General
Market News
Benzinga
From
Benzinga
New Data Reinforce Favorable Safety, Efficacy Of Roche's Hemlibra For Hemophilia A
July 11, 2022
Tickers
RHHBF
RHHBY
RHHVF
Tags
RHHVF
Biotech
Market News
From
Benzinga
The Daily Biotech Pulse: Europe Approves Second Round Of Booster Doses of mRNA COVID-19 Vaccines, Perrigo Seeks Approval For First OTC Birth Control Pill, MacroGenics Closes Head & Cancer Study After
July 11, 2022
Tickers
BIOVF
CANF
IBB
INVA
Tags
Small Cap
Penny Stocks
BIOVF
From
Benzinga
10 Most Traded OTC Stocks In June: Where Do Danone, Adidas And Grayscale Bitcoin Trust Rank?
July 06, 2022
Tickers
ADDYY
BITCOMP
BNPQY
BTC
Tags
ETH
UAA
Retail Stocks
From
Benzinga
Sarepta Reports One Heart Inflammation Case In Duchenne Gene Therapy Trial
July 06, 2022
Tickers
RHHBF
RHHBY
RHHVF
SRPT
Tags
Health Care
News
Briefs
From
Benzinga
< Previous
1
2
...
7
8
9
10
11
12
13
14
15
...
18
19
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.